Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CS9R
|
|||
| Drug Name |
PMID25991433-Compound-B1
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
F. HOFFMANN-LA ROCHE AG ARZENO, Humberto, Bartolome FILONOVA, Lubov GOLDSTEIN, David, Michael GONG, Leyi LOE, Bradley, E. O'BRIEN, Erin, M. PALMER, Wylie, Solang ROTSTEIN, David, Mark SILVA, Tania TAN, Yun-chou
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mitogen-activated protein kinase (MAPK) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Mitogen-activated protein kinase (MAPK) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.